Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Menu
My View
  • Edit
  • Add your favourite topics for quick access
Meet the Team
Ask the Analyst
Partnered Content
PDF Library
RSS Feeds
Subscribe
Advertising
Report Store
UsernamePublicRestriction
Tags:
Pricing Debate Reimbursement Pricing Strategies

US Retail Drug Spending Growth Slows Substantially In 2016

  • Analysis

Executive Summary

Retail drug spending rose just 1.3% in 2016, following growth rates of 8.9% and 12.4% in 2015 and 2014, respectively. Moderating trend is reported just ahead of two congressional hearings on drug pricing.

Table

View full table

Advertisement

Related Content

Pink Sheet
Retail Drug Spending In US Flat For 2017 Due Mainly To 'Non-Price' Factors
Pink Sheet
Impact Of Rebates On Drug Pricing Will Diminish -- CMS Experts
Pink Sheet
Drug Pricing: National Academies Weighs In With Some Familiar Proposals
Pink Sheet
Where Will It End? Lilly’s US Price Concessions Increase 30% In 2016
Pink Sheet
Hep C Drug Trends: Cost Driver In 2014, But “Leveling Off” Coming, CMS Actuaries Say

Topics

Advertisement
Tags:
Pricing Debate Reimbursement Pricing Strategies
UsernamePublicRestriction

Register

PS122094

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By